The medical data provider has now secured almost $78m in total, with Novartis and Qualcomm venture DRx Capital returning for its series B round.
Author: Richard Holliday
The evolving business of materials
Strategically-minded corporate partners with patience, experience and industry value-chain contacts, may be able to exploit a genuinely exciting opportunity.